126 related articles for article (PubMed ID: 32192938)
1. Anti-VEGF Therapy Immediately after Plaque Radiation Therapy Prevents or Delays Radiation Maculopathy.
Powell BE; Finger PT
Ophthalmol Retina; 2020 May; 4(5):547-550. PubMed ID: 32192938
[No Abstract] [Full Text] [Related]
2. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
Finger PT; Mukkamala SK
Eur J Ophthalmol; 2011; 21(4):446-51. PubMed ID: 21218391
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
6. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy.
Finger PT; Chin KJ
Eur J Ophthalmol; 2013; 23(6):850-6. PubMed ID: 23813109
[TBL] [Abstract][Full Text] [Related]
7. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
Retina; 2005; 25(7):868-74. PubMed ID: 16205566
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
[TBL] [Abstract][Full Text] [Related]
10. Anti-Vascular Endothelial Growth Factor Therapy for Radiation Retinopathy.
Rayess N; Mruthyunjaya P
Ophthalmic Surg Lasers Imaging Retina; 2020 Apr; 51(4):S44-S49. PubMed ID: 32348534
[TBL] [Abstract][Full Text] [Related]
11. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
Finger PT; Chin K
Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
[TBL] [Abstract][Full Text] [Related]
13. Aflibercept for Radiation Maculopathy Study: A Prospective, Randomized Clinical Study.
Murray TG; Latiff A; Villegas VM; Gold AS
Ophthalmol Retina; 2019 Jul; 3(7):561-566. PubMed ID: 31277797
[TBL] [Abstract][Full Text] [Related]
14. Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial.
Seibel I; Vollhardt D; Riechardt AI; Rehak M; Schmied S; Schiller P; Zeitz O; Hellmich M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):869-878. PubMed ID: 32112140
[TBL] [Abstract][Full Text] [Related]
15. Current treatments and preventive strategies for radiation retinopathy.
Reichstein D
Curr Opin Ophthalmol; 2015 May; 26(3):157-66. PubMed ID: 25730680
[TBL] [Abstract][Full Text] [Related]
16. RETINAL MICROVASCULAR CHANGES IN UVEAL MELANOMA FOLLOWING CONBERCEPT INJECTION AFTER PLAQUE RADIOTHERAPY AS DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Yang JY; Wang Q; Chen MX; Yan YN; Zhou WJ; Liu YM; Wei WB
Retina; 2021 Dec; 41(12):2605-2611. PubMed ID: 34155168
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
Dalvin LA; Zhang Q; Hamershock RA; Chang M; Yu MD; Mashayekhi A; Shields CL
Br J Ophthalmol; 2020 May; 104(5):697-702. PubMed ID: 31409650
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
19. The use of optical coherence tomography to determine the severity of radiation retinopathy.
Levitz LM
Ophthalmic Surg Lasers Imaging; 2005; 36(5):410-1. PubMed ID: 16238040
[TBL] [Abstract][Full Text] [Related]
20. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
